Porubská M, Krchnavá B, Slámová J, Cepilová Z
OLU RCH, Nový Smokovec.
Cesk Oftalmol. 1991 Nov;47(4):281-5.
The authors investigated in a group of 850 patients the influence of long-term general corticotherapy on the transparency of the lens and intraocular pressure in relation to the length of therapy, dosage, age and sex of the patient. The presence of posterior subcapsular cataract was revealed in 5.2% of the patient, a raised intraocular pressure in 12.8%. The authors reached the conclusion that the duration of corticotherapy did not influence in a substantial way the development of posterior subcapsular cataract nor of cortisone glaucoma. A dose of 10-15 mg per day may be considered marginal for the development of cataract; dosage has no basic effect on the development of glaucoma. The maximum incidence of complications was in advanced age groups. No predisposition as regards sex was observed. A significant role in the development of cortisone cataract and cortisone glaucoma is played by individual sensitivity to corticoids.
作者对850名患者进行了研究,探讨长期全身性皮质激素治疗对晶状体透明度和眼压的影响,以及治疗时长、剂量、患者年龄和性别的关系。结果显示,5.2%的患者出现后囊下白内障,12.8%的患者眼压升高。作者得出结论,皮质激素治疗的时长对后囊下白内障和皮质激素性青光眼的发生并无实质性影响。每天10 - 15毫克的剂量可能被认为是白内障发生的临界剂量;剂量对青光眼的发生没有根本影响。并发症的最高发生率出现在老年人群体中。未观察到性别方面的易感性。个体对皮质激素的敏感性在皮质激素性白内障和皮质激素性青光眼的发生中起重要作用。